Eligibility Liver Cirrhosis NCT01501240

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Descrizione

ID.1

Tipo di dati

boolean

patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Descrizione

ID.2

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients under 20 years of age
Descrizione

ID.3

Tipo di dati

boolean

patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
Descrizione

ID.4

Tipo di dati

boolean

patients who underwent transarterial chemotherapy or radiofrequency ablation
Descrizione

ID.5

Tipo di dati

boolean

women who are pregnant, lactating or who are of childbearing potential
Descrizione

ID.6

Tipo di dati

boolean

patients with any physical or mental status than interferes with the signing of informed consent
Descrizione

ID.7

Tipo di dati

boolean

patients with a contraindication for mr
Descrizione

ID.8

Tipo di dati

boolean

patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Liver Cirrhosis NCT01501240

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
ID.2
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
patients under 20 years of age
boolean
ID.4
Item
patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
boolean
ID.5
Item
patients who underwent transarterial chemotherapy or radiofrequency ablation
boolean
ID.6
Item
women who are pregnant, lactating or who are of childbearing potential
boolean
ID.7
Item
patients with any physical or mental status than interferes with the signing of informed consent
boolean
ID.8
Item
patients with a contraindication for mr
boolean
ID.9
Item
patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
boolean